A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs AZD 8165 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 16 Sep 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Jun 2010 New trial record